Knight Therapeutics Inc T.GUD

Alternate Symbol(s): KHTRF

Healthcare Biotechnology

Knight Therapeutics Inc. is a specialty pharmaceutical company. The Company’s principal business activity is developing, acquiring, in-licensing, out-licensing, manufacturing, marketing and distributing pharmaceutical products in Canada, Latin America and select international markets. It finances other life sciences companies and secures product distribution rights for Canada and select international markets. The Company invests in life sciences venture capital funds whereby the Company may receive preferential access to healthcare products for Canada and select international markets. It develops pharmaceutical products, including those to treat neglected tropical and rare pediatric diseases. The portfolio consists of pharmaceutical products with molecules and includes both in-licensed products such as Lenvima, Cresemba, Halaven, Trelstar, Akynzeo, Ambisome, Minjuvi, Imvexxy as well as products owned by Knight such as Exelon and Impavido.

TSX:GUD - Post by User

Knight Therapeutics Inc

Bullboard Posts

Post by GoldenInvestoron Nov 25, 2019 2:25pm

89 Views

Post# 30390257

Some GUD thoughts

- Volume is now trending around 306,000, double what it used to be , & sometimes recently as high as 560,000+

-

- Volume is moving as traders trying to reposition themselves ages of FRIDAY'S ACQUISITION of over HALF of GRUPO BIOTOSCANA. (GBT)

-

- by causing prices to fluctuate & causing shareholders to sell, Bigger $ firms getting prices to be lower, then will be piling in more so, once they have their targeted amount, will be driving up prices

-

- with JRG and his very GUD team, others are now looking to take advantage of a strong pharma machine with strong proven drug development capabilities ( biotech from GRUPO BIOTOSCANA ) & a HUGE new market, LATAM -10 countries) to sell into as well Native Canada!!

Bullboard Posts

Cizzle Brands, Changing Consumer Habits in Consumables